Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Ischemic Heart Disease

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 147 articles: HTML format Text format

Single Articles

June 2019
1. NAGEL E, Greenwood JP, McCann GP, Bettencourt N, et al
   Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
   N Engl J Med. 2019;380:2418-2428.
   PubMed     Text format     Abstract available
   
   
   
2. HUSAIN M, Birkenfeld AL, Donsmark M, Dungan K, et al
   Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
   N Engl J Med. 2019 Jun 11. doi: 10.1056/NEJMoa1901118.
   PubMed     Text format     Abstract available
   
   
   
3. RIDKER PM
   Methotrexate for Prevention of Cardiovascular Events. Reply.
   N Engl J Med. 2019;380:2277.
   PubMed     Text format    
   
   
   
4. HUANG Y, Chan AW, Shear NH
   Methotrexate for Prevention of Cardiovascular Events.
   N Engl J Med. 2019;380:2277.
   PubMed     Text format    
   
   
   
5. VAN VOLLENHOVEN RF, Nurmohamed M
   Methotrexate for Prevention of Cardiovascular Events.
   N Engl J Med. 2019;380:2276-2277.
   PubMed     Text format    
   
   
   May 2019
6. DE LA FUENTE J, Bird J
   Coronary Arteritis in IgG4-Related Disease.
   N Engl J Med. 2019;380:2156.
   PubMed     Text format    
   
   
   
7. YU D, Blair JEA
   A STEMI Mimic.
   N Engl J Med. 2019;380:e41.
   PubMed     Text format    
   
   
   
8. SCHWARTZ GG, Steg PG, Szarek M
   Alirocumab after Acute Coronary Syndrome. Reply.
   N Engl J Med. 2019;380:2077.
   PubMed     Text format    
   
   
   
9. PIGNATELLI P, Camera M, Violi F
   Alirocumab after Acute Coronary Syndrome.
   N Engl J Med. 2019;380:2076.
   PubMed     Text format    
   
   
   
10. ENNEZAT PV, Hansen MR
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2076.
    PubMed     Text format    
    
    
    
11. LAN NSR, Yeap BB, Fegan PG
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2075-2076.
    PubMed     Text format    
    
    
    
12. ALKHALIL M
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2075.
    PubMed     Text format    
    
    
    
13. GAO Y, Hou B
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2074-2075.
    PubMed     Text format    
    
    
    
14. THIELE H, Schneider S, Desch S
    One-Year Outcomes after PCI Strategies in Cardiogenic Shock. Reply.
    N Engl J Med. 2019;380:1877.
    PubMed     Text format    
    
    
    
15. YAN F, Thall P, Yuan Y
    One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
    N Engl J Med. 2019;380:1876-1877.
    PubMed     Text format    
    
    
    
16. WIVIOTT SD, Raz I, Sabatine MS
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. Reply.
    N Engl J Med. 2019;380:1881-1882.
    PubMed     Text format    
    
    
    
17. AKINCI B
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2019;380:1881.
    PubMed     Text format    
    
    
    
18. BAGLIONI P
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2019;380:1880-1881.
    PubMed     Text format    
    
    
    April 2019
19. BHATT DL, Steg PG, Miller M
    Cardiovascular Risk Reduction with Icosapent Ethyl. Reply.
    N Engl J Med. 2019;380:1678.
    PubMed     Text format    
    
    
    
20. BORGHI C, Fogacci F, Cicero AFG
    Cardiovascular Risk Reduction with Icosapent Ethyl.
    N Engl J Med. 2019;380:1678.
    PubMed     Text format    
    
    
    
21. CHAN LN
    Cardiovascular Risk Reduction with Icosapent Ethyl.
    N Engl J Med. 2019;380:1677.
    PubMed     Text format    
    
    
    
22. MUSHER DM, Abers MS, Corrales-Medina VF
    Acute Infection and Myocardial Infarction. Reply.
    N Engl J Med. 2019;380.
    PubMed     Text format    
    
    
    
23. FRANK RC, Hanidziar D
    Acute Infection and Myocardial Infarction.
    N Engl J Med. 2019;380.
    PubMed     Text format    
    
    
    March 2019
24. LANDONI G, Lomivorotov VV, Nigro Neto C, Monaco F, et al
    Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery.
    N Engl J Med. 2019 Mar 19. doi: 10.1056/NEJMoa1816476.
    PubMed     Text format     Abstract available
    
    
    
25. LEMKES JS, Janssens GN, van der Hoeven NW, Jewbali LSD, et al
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019 Mar 18. doi: 10.1056/NEJMoa1816897.
    PubMed     Text format     Abstract available
    
    
    
26. ABELLA BS, Gaieski DF
    Coronary Angiography after Cardiac Arrest - The Right Timing or the Right Patients?
    N Engl J Med. 2019 Mar 18. doi: 10.1056/NEJMe1901651.
    PubMed     Text format    
    
    
    
27. LOPES RD, Heizer G, Aronson R, Vora AN, et al
    Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMoa1817083.
    PubMed     Text format     Abstract available
    
    
    
28. MEHTA SR
    Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndromes or PCI.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMe1902214.
    PubMed     Text format    
    
    
    
29. FERENCE BA, Ray KK, Catapano AL, Ference TB, et al
    Mendelian Randomization Study of ACLY and Cardiovascular Disease.
    N Engl J Med. 2019;380:1033-1042.
    PubMed     Text format     Abstract available
    
    
    
30. OH J, Kang SM
    Rivaroxaban in Patients with Heart Failure.
    N Engl J Med. 2019;380:988.
    PubMed     Text format    
    
    
    February 2019
31. RIDKER PM, Everett BM, Pradhan A, MacFadyen JG, et al
    Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
    N Engl J Med. 2019;380:752-762.
    PubMed     Text format     Abstract available
    
    
    
32. FAUCHIER L, Clementy N, Bisson A
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2019;380:600.
    PubMed     Text format    
    
    
    
33. STECKER EC, Walsh MN
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2019;380:599.
    PubMed     Text format    
    
    
    
34. 
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2019;380:599-601.
    PubMed     Text format    
    
    
    January 2019
35. TAGGART DP, Benedetto U, Gerry S, Altman DG, et al
    Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years.
    N Engl J Med. 2019;380:437-446.
    PubMed     Text format     Abstract available
    
    
    
36. 
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:298-300.
    PubMed     Text format    
    
    
    
37. CHEUNG BMY
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:299-300.
    PubMed     Text format    
    
    
    
38. SANDHU AT, Maron DJ
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:299.
    PubMed     Text format    
    
    
    
39. BOGATY P, Brophy J
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:298-9.
    PubMed     Text format    
    
    
    
40. KOROSOGLOU G, Giusca S
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:298.
    PubMed     Text format    
    
    
    
41. MUSHER DM, Abers MS, Corrales-Medina VF
    Acute Infection and Myocardial Infarction.
    N Engl J Med. 2019;380:171-176.
    PubMed     Text format    
    
    
    
42. VERMA S, Mazer CD
    Open or Endoscopic Vein Harvesting for Coronary-Artery Bypass Grafting.
    N Engl J Med. 2019;380:189-191.
    PubMed     Text format    
    
    
    December 2018
43. MATSUURA H, Ohya M
    Coronary-Artery Occlusion from Kawasaki's Disease.
    N Engl J Med. 2018;379:e42.
    PubMed     Text format    
    
    
    
44. WADHERA RK, Bhatt DL
    Toward Precision Policy - The Case of Cardiovascular Care.
    N Engl J Med. 2018;379:2193-2195.
    PubMed     Text format    
    
    
    November 2018
45. BURNETT JR, Hooper AJ
    PCSK9 - A Journey to Cardiovascular Outcomes.
    N Engl J Med. 2018;379:2161-2162.
    PubMed     Text format    
    
    
    
46. KOPJAR T, Gasparovic H, Biocina B
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966-7.
    PubMed     Text format    
    
    
    
47. REHMAN SM, Duggan SMJ
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966.
    PubMed     Text format    
    
    
    
48. ALSAGHEIR A, Belley-Cote EP, Whitlock RP
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966.
    PubMed     Text format    
    
    
    
49. 
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966-1968.
    PubMed     Text format    
    
    
    
50. ZENATI MA, Bhatt DL, Bakaeen FG, Stock EM, et al
    Randomized Trial of Endoscopic or Open Vein-Graft Harvesting for Coronary-Artery Bypass.
    N Engl J Med. 2018 Nov 11. doi: 10.1056/NEJMoa1812390.
    PubMed     Text format     Abstract available
    
    
    
51. MANSON JE, Cook NR, Lee IM, Christen W, et al
    Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1811403.
    PubMed     Text format     Abstract available
    
    
    
52. MANSON JE, Cook NR, Lee IM, Christen W, et al
    Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1809944.
    PubMed     Text format     Abstract available
    
    
    
53. BHATT DL, Steg PG, Miller M, Brinton EA, et al
    Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1812792.
    PubMed     Text format     Abstract available
    
    
    
54. WIVIOTT SD, Raz I, Bonaca MP, Mosenzon O, et al
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1812389.
    PubMed     Text format     Abstract available
    
    
    
55. SCHWARTZ GG, Steg PG, Szarek M, Bhatt DL, et al
    Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
    N Engl J Med. 2018 Nov 7. doi: 10.1056/NEJMoa1801174.
    PubMed     Text format     Abstract available
    
    
    
56. ADRIAENSSENS T, Van de Werf F
    Is Culprit-Lesion-Only PCI in Cardiogenic Shock Still Better at 1 Year?
    N Engl J Med. 2018;379:1775-1776.
    PubMed     Text format    
    
    
    
57. THIELE H, Akin I, Sandri M, de Waha-Thiele S, et al
    One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
    N Engl J Med. 2018;379:1699-1710.
    PubMed     Text format     Abstract available
    
    
    October 2018
58. 
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1582-1584.
    PubMed     Text format    
    
    
    
59. MONTENEGRO MF, Lundberg JO, Weitzberg E
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1583-4.
    PubMed     Text format    
    
    
    
60. PEREZ-GOMEZ MV, Bartsch LA, Ortiz A
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1583.
    PubMed     Text format    
    
    
    
61. BHATTACHARYYA S, Macklin EA, Schwarzschild MA
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1582.
    PubMed     Text format    
    
    
    
62. DRAZEN JM
    Expression of Concern: Beltrami AP et al. Evidence That Human Cardiac Myocytes Divide after Myocardial Infarction. N Engl J Med 2001;344:1750-7 and Quaini F et al. Chimerism of the Transplanted Heart. N Engl J Med 2002;346:5-15.
    N Engl J Med. 2018 Oct 17. doi: 10.1056/NEJMe1813801.
    PubMed     Text format    
    
    
    
63. 
    Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.
    N Engl J Med. 2018;379:1486.
    PubMed     Text format    
    
    
    
64. 
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387-1389.
    PubMed     Text format    
    
    
    
65. STEWART RAH
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1388.
    PubMed     Text format    
    
    
    
66. JENKINS D, Sievenpiper J, Jones P
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387-8.
    PubMed     Text format    
    
    
    
67. CORREIA LCL
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387.
    PubMed     Text format    
    
    
    September 2018
68. FIELD ME, Page RL
    Another Shock for Sudden Death Prevention after Myocardial Infarction.
    N Engl J Med. 2018;379:1274-1275.
    PubMed     Text format    
    
    
    
69. OLGIN JE, Pletcher MJ, Vittinghoff E, Wranicz J, et al
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2018;379:1205-1215.
    PubMed     Text format     Abstract available
    
    
    
70. MCNEIL JJ, Wolfe R, Woods RL, Tonkin AM, et al
    Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
    N Engl J Med. 2018 Sep 16. doi: 10.1056/NEJMoa1805819.
    PubMed     Text format     Abstract available
    
    
    August 2018
71. ZANNAD F, Anker SD, Byra WM, Cleland JGF, et al
    Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.
    N Engl J Med. 2018 Aug 27. doi: 10.1056/NEJMoa1808848.
    PubMed     Text format     Abstract available
    
    
    
72. BOHULA EA, Wiviott SD, McGuire DK, Inzucchi SE, et al
    Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808721.
    PubMed     Text format     Abstract available
    
    
    
73. MAZER CD, Whitlock RP, Fergusson DA, Belley-Cote E, et al
    Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808561.
    PubMed     Text format     Abstract available
    
    
    
74. 
    Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.
    N Engl J Med. 2018 Aug 25. doi: 10.1056/NEJMoa1805971.
    PubMed     Text format     Abstract available
    
    
    
75. HOFFMANN U, Udelson JE
    Imaging Coronary Anatomy and Reducing Myocardial Infarction.
    N Engl J Med. 2018 Aug 25. doi: 10.1056/NEJMe1809203.
    PubMed     Text format    
    
    
    
76. RAWSHANI A, Rawshani A, Franzen S, Sattar N, et al
    Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2018;379:633-644.
    PubMed     Text format     Abstract available
    
    
    
77. WEINER RB, Hucker WJ, Meyersohn NM, Dudzinski DM, et al
    Case 25-2018: A 63-Year-Old Man with Syncope.
    N Engl J Med. 2018;379:670-680.
    PubMed     Text format    
    
    
    July 2018
78. XAPLANTERIS P, Fournier S, Pijls NHJ, Fearon WF, et al
    Five-Year Outcomes with PCI Guided by Fractional Flow Reserve.
    N Engl J Med. 2018;379:250-259.
    PubMed     Text format     Abstract available
    
    
    June 2018
79. CUERVO G, Viasus D, Carratala J
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2540.
    PubMed     Text format    
    
    
    
80. BUCKLEY LF
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539-40.
    PubMed     Text format    
    
    
    
81. CASTILLO-RODRIGUEZ E, Fernandez-Prado R, Ortiz A
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539.
    PubMed     Text format    
    
    
    
82. WIESSMAN M, Shlomai A
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539.
    PubMed     Text format    
    
    
    
83. WAXMAN DA, Kanzaria HK, Schriger DL
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2538-9.
    PubMed     Text format    
    
    
    
84. 
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2538-2541.
    PubMed     Text format    
    
    
    
85. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
    Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013;368:1279-90.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMc1806491.
    PubMed     Text format    
    
    
    
86. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMoa1800389.
    PubMed     Text format     Abstract available
    
    
    
87. ARBOINE L, Palacios JM
    Left Main Coronary Artery Aneurysm.
    N Engl J Med. 2018;378:e32.
    PubMed     Text format    
    
    
    May 2018
88. SHAPIRA OM
    Radial Artery as the Preferred Second Conduit for Coronary Bypass.
    N Engl J Med. 2018;378:2134-2135.
    PubMed     Text format    
    
    
    
89. JOHNSTON SC, Easton JD, Farrant M, Barsan W, et al
    Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1800410.
    PubMed     Text format     Abstract available
    
    
    April 2018
90. GAUDINO M, Benedetto U, Fremes S, Biondi-Zoccai G, et al
    Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018 Apr 30. doi: 10.1056/NEJMoa1716026.
    PubMed     Text format     Abstract available
    
    
    
91. CAMPBELL BCV, Mitchell PJ, Churilov L, Yassi N, et al
    Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    N Engl J Med. 2018;378:1573-1582.
    PubMed     Text format     Abstract available
    
    
    
92. BAIRD AE
    Paving the Way for Improved Treatment of Acute Stroke with Tenecteplase.
    N Engl J Med. 2018;378:1635-1636.
    PubMed     Text format    
    
    
    
93. ZHAO YT, Huang YS
    ECG Pattern Associated with Left Anterior Descending Coronary Artery Occlusion.
    N Engl J Med. 2018;378:e22.
    PubMed     Text format    
    
    
    
94. AMELOOT K, Daemen J, Van Mieghem N
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1360-1.
    PubMed     Text format    
    
    
    
95. PAPPALARDO F, Bertoldi L
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1360.
    PubMed     Text format    
    
    
    
96. PASCERI V, Pelliccia F, Speciale G
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1359-60.
    PubMed     Text format    
    
    
    
97. FERREIRA RM, Salis LHA, e Silva NAS
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1359.
    PubMed     Text format    
    
    
    
98. FLEISSNER F, Haverich A, Warnecke G
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358-9.
    PubMed     Text format    
    
    
    
99. SHARMA S, Lardizabal J
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358.
    PubMed     Text format    
    
    
    
100. 
     PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
     N Engl J Med. 2018;378:1358-1361.
     PubMed     Text format    
     
     
     March 2018
101. LOSCALZO J, Roy N, Shah RV, Tsai JN, et al
     Case 8-2018: A 55-Year-Old Woman with Shock and Labile Blood Pressure.
     N Engl J Med. 2018;378:1043-1053.
     PubMed     Text format    
     
     
     
102. WHITE WB, Saag KG, Becker MA, Borer JS, et al
     Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
     N Engl J Med. 2018 Mar 12. doi: 10.1056/NEJMoa1710895.
     PubMed     Text format     Abstract available
     
     
     
103. LEE F, Maggiore P, Chung K
     Self-Management of an Inferior ST-Segment Elevation Myocardial Infarction.
     N Engl J Med. 2018;378:960-962.
     PubMed     Text format    
     
     
     February 2018
104. 
     Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
     N Engl J Med. 2018;378:782.
     PubMed     Text format    
     
     
     January 2018
105. FAUCHIER L, Bisson A, Angoulvant D
     Rivaroxaban in Stable Cardiovascular Disease.
     N Engl J Med. 2018;378:395.
     PubMed     Text format    
     
     
     
106. KWONG JC, Schwartz KL, Campitelli MA, Chung H, et al
     Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
     N Engl J Med. 2018;378:345-353.
     PubMed     Text format     Abstract available
     
     
     
107. CAHILL TJ, Wijesurendra RS, Casadei B
     Rivaroxaban in Stable Cardiovascular Disease.
     N Engl J Med. 2018;378:397.
     PubMed     Text format    
     
     
     
108. HELFT G, Le Feuvre C, Zaman A
     Rivaroxaban in Stable Cardiovascular Disease.
     N Engl J Med. 2018;378:397.
     PubMed     Text format    
     
     
     
109. JEONG YH, Bae JS, Gurbel PA
     Rivaroxaban in Stable Cardiovascular Disease.
     N Engl J Med. 2018;378:396.
     PubMed     Text format    
     
     
     
110. AJANI AE
     Rivaroxaban in Stable Cardiovascular Disease.
     N Engl J Med. 2018;378:395-6.
     PubMed     Text format    
     
     
     
111. 
     Rivaroxaban in Stable Cardiovascular Disease.
     N Engl J Med. 2018;378:395-398.
     PubMed     Text format    
     
     
     
112. FAUCHIER L, Bisson A, Angoulvant D
     Rivaroxaban in Stable Cardiovascular Disease.
     N Engl J Med. 2018;378:395.
     PubMed     Text format    
     
     
     
113. WEBSTER MWI, Stables RH
     Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
     N Engl J Med. 2018;378:299.
     PubMed     Text format    
     
     
     
114. SHAH R
     Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
     N Engl J Med. 2018;378:299.
     PubMed     Text format    
     
     
     
115. VIJ A, Kodumuri V
     Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
     N Engl J Med. 2018;378:298.
     PubMed     Text format    
     
     
     
116. BULLUCK H
     Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
     N Engl J Med. 2018;378:298.
     PubMed     Text format    
     
     
     
117. 
     Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
     N Engl J Med. 2018;378:298-301.
     PubMed     Text format    
     
     
     
118. STONE GW
     Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
     N Engl J Med. 2018;378:300-1.
     PubMed     Text format    
     
     
     
119. 
     Oxygen Therapy in Suspected Acute Myocardial Infarction.
     N Engl J Med. 2018;378:200-202.
     PubMed     Text format    
     
     
     
120. LELLOUCHE F, Simon M, L'Her E
     Oxygen Therapy in Suspected Acute Myocardial Infarction.
     N Engl J Med. 2018;378:201.
     PubMed     Text format    
     
     
     
121. SAMADANI U, Affana CK
     Oxygen Therapy in Suspected Acute Myocardial Infarction.
     N Engl J Med. 2018;378:200-1.
     PubMed     Text format    
     
     
     
122. ROSENBAUM L
     Swallowing a Spy - The Potential Uses of Digital Adherence Monitoring.
     N Engl J Med. 2018;378:101-103.
     PubMed     Text format    
     
     
     December 2017
123. IMPRIALOS KP, Stavropoulos K, Doumas M
     Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
     N Engl J Med. 2017;377:2502.
     PubMed     Text format    
     
     
     
124. HOLMAN RR, Bethel MA, Hernandez AF
     Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
     N Engl J Med. 2017;377:2502.
     PubMed     Text format    
     
     
     
125. TSIARAS SV, Safi LM, Ghoshhajra BB, Lindsay ME, et al
     Case 39-2017. A 41-Year-Old Woman with Recurrent Chest Pain.
     N Engl J Med. 2017;377:2475-2484.
     PubMed     Text format    
     
     
     
126. KELLY NP, Gerhard-Herman M, Desai AS, Miller AL, et al
     An Unusual Cause of Leg Pain.
     N Engl J Med. 2017;377:2267-2272.
     PubMed     Text format    
     
     
     November 2017
127. 
     Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
     N Engl J Med. 2017;377:2097-2099.
     PubMed     Text format    
     
     
     
128. RAJAGOPALAN S, Brook R
     Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
     N Engl J Med. 2017;377:2098-9.
     PubMed     Text format    
     
     
     
129. FERNANDEZBALSELLS MM, Sojo-Vega L, Ricart-Engel W
     Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
     N Engl J Med. 2017;377:2098.
     PubMed     Text format    
     
     
     
130. BAGLIONI P
     Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
     N Engl J Med. 2017;377:2097-8.
     PubMed     Text format    
     
     
     
131. KELLY NP, Vaidya A, Gerhard-Herman M, Desai AS, et al
     An Unusual Cause of Leg Pain.
     N Engl J Med. 2017;377:e29.
     PubMed     Text format    
     
     
     
132. MAZER CD, Whitlock RP, Fergusson DA, Hall J, et al
     Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery.
     N Engl J Med. 2017 Nov 12. doi: 10.1056/NEJMoa1711818.
     PubMed     Text format     Abstract available
     
     
     
133. JACOB KA, Gianoli M, van Dijk D
     Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
     N Engl J Med. 2017;377:1897-8.
     PubMed     Text format    
     
     
     
134. TAGGART DP, Puskas JD
     Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
     N Engl J Med. 2017;377:1897.
     PubMed     Text format    
     
     
     
135. JONES SG, Pullan MD, Kirmani BH
     Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
     N Engl J Med. 2017;377:1896-7.
     PubMed     Text format    
     
     
     
136. NOZAWA T, Imagawa T, Ito S
     Coronary-Artery Aneurysm in Tocilizumab-Treated Children with Kawasaki's Disease.
     N Engl J Med. 2017;377:1894-1896.
     PubMed     Text format    
     
     
     
137. 
     Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
     N Engl J Med. 2017;377:1898-1899.
     PubMed     Text format    
     
     
     October 2017
138. THIELE H, Akin I, Sandri M, Fuernau G, et al
     PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.
     N Engl J Med. 2017 Oct 30. doi: 10.1056/NEJMoa1710261.
     PubMed     Text format     Abstract available
     
     
     
139. MONTONE RA, Minelli S
     Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
     N Engl J Med. 2017;377:1595-6.
     PubMed     Text format    
     
     
     
140. AGGARWAL S, Pavlides G
     Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
     N Engl J Med. 2017;377:1595.
     PubMed     Text format    
     
     
     
141. BHATT DL
     Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
     N Engl J Med. 2017;377:1598-1599.
     PubMed     Text format    
     
     
     
142. DAVIES JE, Sen S, Escaned J
     Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
     N Engl J Med. 2017;377:1597-1598.
     PubMed     Text format    
     
     
     
143. PIJLS NHJ, De Bruyne B
     Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
     N Engl J Med. 2017;377:1596.
     PubMed     Text format    
     
     
     
144. 
     Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
     N Engl J Med. 2017;377:1596-7.
     PubMed     Text format    
     
     
     September 2017
145. BOWMAN L, Hopewell JC, Chen F, Wallendszus K, et al
     Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
     N Engl J Med. 2017;377:1217-1227.
     PubMed     Text format     Abstract available
     
     
     
146. RIDKER PM, Everett BM, Thuren T, MacFadyen JG, et al
     Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
     N Engl J Med. 2017;377:1119-1131.
     PubMed     Text format     Abstract available
     
     
     
147. HOLMAN RR, Bethel MA, Mentz RJ, Thompson VP, et al
     Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
     N Engl J Med. 2017 Sep 14. doi: 10.1056/NEJMoa1612917.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: